Cancer Causes & Control

, Volume 12, Issue 10, pp 959–964

Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy

  • Francesco Donato
  • Umberto Gelatti
  • Alessandro Tagger
  • Maurizio Favret
  • Maria Lisa Ribero
  • Francesco Callea
  • Claudia Martelli
  • Antonella Savio
  • Paola Trevisi
  • Giuseppe Nardi
Article

Abstract

Objective: Intrahepatic cholangiocarcinoma (ICC) is a rare type of primary liver cancer (PLC) arising from intrahepatic bile ducts. We carried out a case–control study to assess the association between ICC and hepatitis B and C virus (HBV and HCV) infections, alcohol intake, and hepatolithiasis in Brescia, North Italy. Methods: Among 370 subjects with histology-based diagnosis of PLC who were resident in the area and hospitalized in 1995–2000, 26 (7%) ICC cases were identified. A total of 824 subjects unaffected by hepatic diseases and frequency-matched with PLC cases by age, sex, date, and hospital of admission were recruited as controls. Results: Among ICC cases the mean age was 65 years, 80.8% were males, and 38.5% had cirrhosis. Seropositivity for anti-HCV, HBsAg, alcohol intake > 80 g/day and history of hepatolithiasis were found in 25%, 13%, 23.1%, and 26.9% of ICC cases and in 5.8%, 6.7%, 32.9%, and 10.6% of controls, respectively. The odds ratios adjusted for demographic factors by logistic regression (95% confidence interval; 95% CI) were 9.7 (1.6–58.9) for anti-HCV, 2.7 (0.4–18.4) for HBsAg, and 6.7 (1.3–33.4) for hepatolithiasis, whereas no association was found with alcohol drinking. Conclusions: HCV and hepatolithiasis may be risk factors for ICC in Western countries.

hepatitis B virus hepatitis C virus hepatolithiasis intrahepatic cholangiocarcinoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    De Groen PC, Gores GJ, LaRusso NF, Gundrson LL, Nagorney DM (1999) Biliary tract cancers. N Engl J Med 341: 1368-1378.Google Scholar
  2. 2.
    Parkin DM, Oshima H, Srivatanakul P, Vatanasapt V (1993) Cholangiocarcinoma: epidemiology, mechanism of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev 2: 537-544.Google Scholar
  3. 3.
    Chalasani N, Baluyut A, Ismail A et al. (2000) Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 31: 7-11.Google Scholar
  4. 4.
    Kornfeld D, Ekbom A, Ihre T (1997) Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. Scand J Gastroenterol 32: 1042-1045.Google Scholar
  5. 5.
    Broomè U, Olsson R, Lööf L, et al. (1996) Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38: 610-615.Google Scholar
  6. 6.
    Farrant JM, Hayllar KM, Wilkinson ML, et al. (1991) Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100: 1710-1717.Google Scholar
  7. 7.
    Farges O, Malassagne B, Sebagh M, Bismuth H (1995) Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 117: 146-155.Google Scholar
  8. 8.
    Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F (1994) Risk factors in primary sclerosing cholangitis. J Hepatol 21: 1061-1066.Google Scholar
  9. 9.
    Kubo S, Kinoshita H, Hirohashi K, Hamba H (1995) Hepatolithiasis associated with cholangiocarcinoma. World J Surg 19: 637-641.Google Scholar
  10. 10.
    Su CH, Shyr YM, Lui WY, P'Eng FK (1997) Hepatolithiasis associated with cholangiocarcinoma. Br J Surg 84: 969-975.Google Scholar
  11. 11.
    Chen MF, Jan YY, Wang CS, et al. (1993) A reappraisal of cholangiocarcinoma in patients with hepatolithiasis. Cancer 71: 2461-2465.Google Scholar
  12. 12.
    Chen MF, Jan YY, Jeng LB, et al. (1999) Intrahepatic cholangiocarcinoma in Taiwan. J Hepatobiliary Pancreat Surg 6: 136-141.Google Scholar
  13. 13.
    Kaczynski J, Hansson G, Wallerstedt S (1998) Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma. Acta Oncol 37: 77-83.Google Scholar
  14. 14.
    Koga A, Ichimiya H, Yamaguchi K, Miyazaki K, Nakayama F (1985) Hepatolithiasis associated with cholangiocarcinoma. Cancer 55: 2826-2829.Google Scholar
  15. 15.
    Chijiiwa K, Ichimiya H, Kuroki S, Koga A, Nakayama F (1993) Late development of cholangiocarcinoma after the treatment of hepatolithiasis. Surg Gynecol Obstet 177: 279-282.Google Scholar
  16. 16.
    Okuda K, Kubo Y, Okazaki N, et al. (1977) Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma. Cancer 39: 232-246.Google Scholar
  17. 17.
    International Agency for Research on Cancer (1988) Alcohol Drinking. IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC.Google Scholar
  18. 18.
    International Agency for Research on Cancer (1994) Hepatitis viruses. IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC.Google Scholar
  19. 19.
    Altaee MY, Johnson PJ, Farrant JM, Williams R (1991) Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer 68: 2051-2055.Google Scholar
  20. 20.
    Hardell L, Bengtsson NO, Jonsson U, Eriksson S, Larsson LG (1984) Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria: an epidemiological investigation. Br J Cancer 50: 389-397.Google Scholar
  21. 21.
    Parkin DM, Srivatanakul P, Khlat M, et al. (1991) Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer 48: 323-328.Google Scholar
  22. 22.
    Tomimatsu M, Ishiguro N, Taniai M, et al. (1993) Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 72: 683-688.Google Scholar
  23. 23.
    Yamamoto M, Takasaki K, Nakano M, Saito A (1998) Minute nodular intrahepatic cholangiocarcinoma. Cancer 82: 2145-2149.Google Scholar
  24. 24.
    Songsivilai S, Dharakul T, Kanistanon D (1996) Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand. Trans R Soc Trop Med Hyg 90: 505-507.Google Scholar
  25. 25.
    Kobayashi M, Ikeda K, Saitoh S, et al. (2000) Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 88: 2471-2477.Google Scholar
  26. 26.
    Sorensen HT, Friis S, Olsen JH, et al. (1998) Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 28: 921-925.Google Scholar
  27. 27.
    Shin H, Lee C, Park H, et al. (1996) Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case control study in Pusan, Korea. Int J Epidemiol 25: 933-940.Google Scholar
  28. 28.
    Donato F, Tagger A, Chiesa R, et al. (1997) Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma: a case-control study in Italy. Hepatology 26: 579-584.Google Scholar
  29. 29.
    Tagger A, Donato F, Ribero ML, et al. (1999) Case-control study on hepatitis C virus as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Int J Cancer 81: 695-699.Google Scholar
  30. 30.
    Corrao G, Busellu G, Valenti M, et al. (1994) Reproducibility of measuring lifetime alcohol consumption by a simple interviewadministered questionnaire. Alcologia 6: 127-135.Google Scholar
  31. 31.
    Rothman KJ (1986) Modern Epidemiology. Boston, MA: Little, Brown & Co.Google Scholar
  32. 32.
    Chiesa R, Donato F, Tomasoni S, Portolani N, Favret M, Nardi G (1995) Primary liver cancer in a high-incidence area in North Italy: etiological hypothesis arising from routinely collected data. Eur J Epidemiol 11: 435-442.Google Scholar
  33. 33.
    Zanetti R, Crosignani P, Rosso S (1997) Cancer in Italy — Incidence Data from Cancer Registries, vol. 2: 1988–1992. Torino: Il Pensiero Scientifico Editore, p. 85.Google Scholar
  34. 34.
    Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan. Clinicopathological features and results of surgical treatment. Ann Surg 211: 277-287.Google Scholar
  35. 35.
    Broomè U, Löfberg R, Veress B, Eriksson LS (1995) Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 22: 1404-1408.Google Scholar
  36. 36.
    Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G (1996) Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicenter study. Eur J Gastroenterol Hepatol 8: 685-691.Google Scholar
  37. 37.
    Attili AF, Carulli N, Roda E, et al. (1995) Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study Group on Cholclithiasis (M.I.COL.) Am J Epidemiol 141: 158-165.Google Scholar
  38. 38.
    Holzinger F, Z'graggen K, Büchler MW (1999) Mechanism of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma. Ann Oncol 10(Suppl. 4): S122-S126.Google Scholar
  39. 39.
    Nakanuma Y, Terada T, Tanaka Y, Ohta G (1985) Are hepatolithiasis and cholangiocarcinoma aetiologically related? Virchows Arch A Pathol Anat Histopathol 406: 45-58.Google Scholar
  40. 40.
    Bergquist A, Glaumann H, Persson B, Broomè U (1998) Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 27: 311-316.Google Scholar
  41. 41.
    Munoz N, Bosch X (1990) Epidemiology of hepatocellular carcinoma. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo: Springer Verlag, pp. 3-19.Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • Francesco Donato
    • 1
  • Umberto Gelatti
  • Alessandro Tagger
    • 2
  • Maurizio Favret
    • 3
  • Maria Lisa Ribero
    • 4
  • Francesco Callea
    • 5
  • Claudia Martelli
  • Antonella Savio
    • 6
  • Paola Trevisi
  • Giuseppe Nardi
  1. 1.Cattedra di IgieneUniversità di BresciaItaly
  2. 2.Istituto di VirologiaUniversità di MilanoItaly
  3. 3.Cattedra di Anatomia PatologicaUniversità di BresciaItaly
  4. 4.Istituto d'IgieneUniversità di MilanoItaly
  5. 5.Servizio di Anatomia Patologica I Spedali Civili di BresciaItaly
  6. 6.Servizio di Anatomia Patologica Ospedale S. OrsolaBresciaItaly

Personalised recommendations